Sorafenib in metastatic uveal melanoma: efficacy, toxicity and health-related quality of life in a multicentre phase II study

BACKGROUND: The aim of the study was to analyse efficacy, safety, and health-related quality of life (HRQoL) for sorafenib treatment in patients with metastatic uveal melanoma. METHODS: A multicentre, single-arm phase II trial was conducted. The primary objective was to determine the non-progression...

Descripción completa

Detalles Bibliográficos
Autores principales: Mouriaux, F, Servois, V, Parienti, J J, Lesimple, T, Thyss, A, Dutriaux, C, Neidhart-Berard, E M, Penel, N, Delcambre, C, Peyro Saint Paul, L, Pham, A D, Heutte, N, Piperno-Neumann, S, Joly, F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931363/
https://www.ncbi.nlm.nih.gov/pubmed/27253171
http://dx.doi.org/10.1038/bjc.2016.119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931363/
https://www.ncbi.nlm.nih.gov/pubmed/27253171
http://dx.doi.org/10.1038/bjc.2016.119

Ejemplares similares